419 / 1631
Cohort C: NR (19, NE
)
Cohort B: NR (NE, NE)
Cohort A : NR (NE, NE)
0.0
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0
3
6
9
12
15
18
Probability of survival
OS (months)
0.2
0.1
BV naïve (Cohort A)
BV after auto-HSCT (Cohort B)
BV before and/or after auto-HSCT (Cohort C)
Number of patients at risk
Cohort A
Cohort B
Cohort C
36
63
17
63
80
100
61
78
97
61
75
93
59
74
90
55
71
83
54
68
65
Engert et al, EHA 2017
Phase 2 CheckMate 205
Overall Survival